UTERINE CARCINOSARCOMA
Clinical trials for UTERINE CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UTERINE CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for UTERINE CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis early-stage study tests an experimental oral drug called NKT5097 in adults with advanced solid tumors, especially breast cancer and tumors with a specific gene change (CCNE1). The main goals are to find a safe dose and see how well the drug works. About 361 participants will…
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:14 UTC
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental pill, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The drug works by blocking a protein that helps cancer cells divide. The trial has two parts: first finding a safe dose, then checking if it shrinks …
Matched conditions: UTERINE CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC